Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome

BACKGROUND: Hepatorenal syndrome is a potentially reversible renal failure associated with severe liver disease. The disease is relatively common among people with decompensated cirrhosis. Terlipressin is a drug that increases the blood flow to the kidneys by constricting blood vessels. The previous...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Allegretti, Andrew S, Israelsen, Mads, Krag, Aleksander, Jovani, Manol, Goldin, Alison H, Schulman, Allison R, Winter, Rachel W, Gluud, Lise Lotte
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2017
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481608/
https://ncbi.nlm.nih.gov/pubmed/29943803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005162.pub4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars